• 1. Synthesis of solandelactone F, constanolactone A and an advanced intermediate towards solandelactone E from a common synthetic intermediate
  Raju Yalla,Sadagopan Raghavan Org. Biomol. Chem. 2019 17 4572
• 2. Synthesis of linoleic acid with chiral isotopic labelling at a flanking and a medial allylic methylene: the (8R,9Z,12Z)-[8-2H] and (11R,9Z,12Z)-[11-2H]-stereoisomers, and (Z)-[2,2-2H2]non-3-enal
  Leslie Crombie,Andrew D. Heavers J. Chem. Soc. Perkin Trans. 1 1992 1929
• 3. Stereoselective three-component cascade synthesis of α-substituted 2,4-dienamides from gem-difluorochloro ethanes
  Shyamsundar Das,Nakeun Ko,Eunsung Lee,Sang Eun Kim,Byung Chul Lee Chem. Commun. 2019 55 14355
• 4. A direct route to conjugated enediynes from dipropargylic sulfones by a modified one-flask Ramberg–B?cklund reaction
  Xiaoping Cao,Yuying Yang,Xiaolong Wang J. Chem. Soc. Perkin Trans. 1 2002 2485
• 5. Toxicity of propargylic alcohols on green alga—Pseudokirchneriella subcapitata
  Chung Yuan Chen,Kwan-Liang Kuo,Je-Wei Fan J. Environ. Monit. 2012 14 181

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty alcohols
• Solvents and Organic Chemicals Organic Compounds Alcohol/Ether

Recent Advances in the Application of 2-Octyn-1-ol (CAS: 20739-58-6) in Chemical Biology and Pharmaceutical Research

2-Octyn-1-ol (CAS: 20739-58-6) is a terminal alkyne alcohol that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a valuable building block in organic synthesis, particularly in click chemistry reactions, where its alkyne functionality enables efficient conjugation with azide-containing molecules. Recent studies have explored its potential in drug discovery, material science, and bioconjugation strategies, highlighting its importance as a multifunctional reagent.

One of the most notable advancements involves the use of 2-Octyn-1-ol in the development of novel antimicrobial agents. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy as a precursor for synthesizing alkynyl-modified antibiotics. The researchers utilized copper-catalyzed azide-alkyne cycloaddition (CuAAC) to conjugate 2-Octyn-1-ol with azide-functionalized quinolones, resulting in derivatives with enhanced activity against drug-resistant bacterial strains. The study reported a 2- to 4-fold increase in potency compared to parent compounds, underscoring the potential of this approach in addressing antibiotic resistance.

In the field of material science, 2-Octyn-1-ol has been employed as a surface modifier for nanoparticles. A recent publication in ACS Nano described its use in creating stable, functionalized gold nanoparticles for targeted drug delivery. The terminal hydroxyl group allows for further derivatization with targeting ligands, while the alkyne moiety enables subsequent bioconjugation. This dual functionality makes 2-Octyn-1-ol particularly valuable for designing sophisticated drug delivery systems with precise control over surface chemistry.

From a synthetic chemistry perspective, researchers have developed improved protocols for the large-scale production of 2-Octyn-1-ol. A 2024 study in Organic Process Research & Development presented an optimized catalytic hydrogenation method that achieves higher yields (up to 92%) while maintaining excellent stereoselectivity. This advancement addresses previous challenges in industrial-scale production, potentially lowering the cost of this valuable intermediate and facilitating its broader application in pharmaceutical manufacturing.

The compound's unique chemical properties have also found applications in chemical biology for protein labeling and tracking. Recent work published in Nature Chemical Biology detailed a novel methodology using 2-Octyn-1-ol derivatives as bioorthogonal probes for live-cell imaging. The researchers demonstrated that these probes exhibit superior membrane permeability and lower cytotoxicity compared to conventional alternatives, enabling longer-term observation of cellular processes without significant interference.

Looking forward, the pharmaceutical industry is exploring 2-Octyn-1-ol's potential in the development of covalent inhibitors. Its alkyne group can form irreversible bonds with specific amino acid residues in target proteins, offering a promising strategy for designing highly selective therapeutics. Preliminary results from several drug discovery programs suggest that this approach may be particularly effective for challenging targets such as protein-protein interactions, where traditional small-molecule inhibitors have struggled to achieve sufficient potency.

In conclusion, 2-Octyn-1-ol (CAS: 20739-58-6) continues to emerge as a versatile and valuable compound in chemical biology and pharmaceutical research. Its applications span from antimicrobial development to advanced drug delivery systems and innovative chemical biology tools. As synthetic methodologies improve and our understanding of its reactivity expands, we anticipate seeing even more creative applications of this molecule in addressing complex challenges in medicine and biotechnology.

• 1002-36-4(2-Heptyn-1-ol)
• 5921-73-3(2-Nonyn-1-ol)
• 2834-00-6(2-Pentadecyn-1-ol)
• 51887-25-3(2-tridecyn-1-ol)
• 51309-22-9(2-Tetradecyn-1-ol)
• 69064-46-6(dodec-2-yn-1-ol)
• 21390-02-3(2,8-Decadiyne-1,10-diol)
• 162551-94-2(2,8-Nonadiyn-1-ol)
• 4117-14-0(2-Decyn-1-ol)
• 34683-71-1(undec-2-yn-1-ol)